Clinical Trial Update: A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/Phase 2 study evaluating the combination of durvalumab with hypofractionated stereotactic radiati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED